Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-08-19

FDA Approved: IVERMECTIN — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

FDA approved a supplemental application for IVERMECTIN from Edenbridge Pharmaceuticals LLC (ANDA 204154). This action updates the approval status for the generi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

SUPPL AP for IVERMECTIN (IVERMECTIN)